Product NDC: | 16729-020 |
Proprietary Name: | Pioglitazone Hydrochloride |
Non Proprietary Name: | pioglitazone hydrochloride |
Active Ingredient(s): | 15 mg/1 & nbsp; pioglitazone hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16729-020 |
Labeler Name: | Accord Healthcare Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200044 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130213 |
Package NDC: | 16729-020-16 |
Package Description: | 500 TABLET in 1 BOTTLE (16729-020-16) |
NDC Code | 16729-020-16 |
Proprietary Name | Pioglitazone Hydrochloride |
Package Description | 500 TABLET in 1 BOTTLE (16729-020-16) |
Product NDC | 16729-020 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pioglitazone hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130213 |
Marketing Category Name | ANDA |
Labeler Name | Accord Healthcare Inc. |
Substance Name | PIOGLITAZONE HYDROCHLORIDE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |